Overview

Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure

Status:
Recruiting

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

This is a randomized, double-blind, placebo-controlled trial evaluating the effect of resveratrol on metabolic and skeletal muscle function. Patients will be randomized and allocated to either resveratrol or placebo, for 8 weeks with a 2-week run-in period before the intervention period (to ensure they are not on any nutritional supplement that contains resveratrol).

Phase:

Phase 2

Details

Lead Sponsor:

University of Alberta

Treatments:

Resveratrol